CORD-19:e847d433e7424152a9846673209cb73027415ecd / 380817-380908 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/e847d433e7424152a9846673209cb73027415ecd","sourcedb":"CORD-19","sourceid":"e847d433e7424152a9846673209cb73027415ecd","text":"Develop a panel of human anti-rubella immunoassays on a high throughput automated platform.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3494","span":{"begin":0,"end":91},"obj":"Sentence"},{"id":"T40120","span":{"begin":0,"end":91},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T3494","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T40120","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T361","span":{"begin":0,"end":91},"obj":"Sentence"}],"attributes":[{"subj":"T361","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1280","span":{"begin":30,"end":37},"obj":"Disease"},{"id":"T1230","span":{"begin":30,"end":37},"obj":"Disease"}],"attributes":[{"id":"A1280","pred":"mondo_id","subj":"T1280","obj":"http://purl.obolibrary.org/obo/MONDO_0004656"},{"id":"A39682","pred":"mondo_id","subj":"T1230","obj":"http://purl.obolibrary.org/obo/MONDO_0004656"},{"subj":"T1280","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T1230","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#eccd93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#b393ec"},{"id":"CORD-19-PD-MONDO","color":"#93ec99"}]}]}}